Tech 🤝 Life Science: How Investors & Companies View the Potential of AI

​While advancements in artificial intelligence (AI) are attracting attention across the entire innovation economy, few sectors stand to benefit more than healthcare. Over the last five years, AI deal activity has grown faster in healthcare than in tech overall, as investors and innovators recognize AI’s potential to improve administrative efficiency, patient diagnostics, drug discovery and more. Join prominent investors and operators for a discussion on how these new technologies are impacting the industry today and a perspective on areas that stand to benefit the most from adoption.

​

​Panelist: Joe Victor (Rarecyte), Daniel Adriano Silva (Monod), Chris Picado (Madrona), Peter Sletteland (SVB)

​Please join SVB at our Downtown Seattle office Conference Center for a spirited panel discussion.

​We look forward to seeing you there!

​